APP and memory impairment: As a result, the COX-2 inhibitor (meloxicam) significantly inhibited memory impairment, neuronal necrosis, oxidative stress, and inflammatory response, and significantly downregulated the expression of APP, Aβ, COX2, whereas it significantly increased exploring behavior.